Abstract:Human leukocyte antigen-G (HLA-G) has been widely acknowledged to play critical roles in fetal-maternal maintenance. However, the significance of using maternal serum sHLA-G to detect prenatal chromosomal abnormality has not been investigated. In China, prenatal screening using maternal α-fetoprotein (AFP), unconjugated estriol (uE3), and free β subunit human chorionic gonadotropin (β-hCG) in the second trimester has been widely applied. In this study, we evaluated the use of sHLA-G as a screening marker, compared with traditional second trimester prenatal screening. Serum samples from 1,019 singleton women in their second trimester were assessed. Among them, 139 infants were confirmed with trisomy 21 (T21) by karyotyping, 83 were confirmed with trisomy 18 (T18), and the remaining 797 infants had no abnormalities. The sHLA-G levels in maternal sera were significantly lower in pregnant women with T18 fetuses (median: 47.8 U/ml, range: 9.8-234.2 U/ml) and significantly higher in those with T21 fetuses (median: 125.7 U/ml, range: 28.7-831.7 U/ml), compared with the normal controls (median: 106.3 U/ml, range: 50.5-1136.4 U/ml) (p < 0.001). The risk values of the screening of T21 or T18 fetuses were assessed using mean and standard deviation log10 analyte multiples of median (MoM) which showed that the predictive values of sHLA-G were the same as free β-hCG, and superior to AFP and uE3 for T18 screening. Logistic regression analysis revealed that sHLA-G MoM was the highest risk factor associated with pregnant women carrying T18 fetuses [Exp(B): 171.26, 95% CI: 36.30-807.97, p < 0.001]. Receiver operating characteristic (ROC) analysis revealed that the area under ROC curve for sHLA-G MoM was 0.915 (95% CI, 0.871-0.959, p < 0.001), for AFP MoM was 0.796 (95% CI, 0.730-0.861, p < 0.001), for free β-hCG MoM was 0.881 (95% CI, 0.829-0.934, p < 0.001), and for uE3 MoM was 0.876 (95% CI, 0.828-0.923, p < 0.001) in the T18 group. sHLA-G MoM demonstrated the best sensitivity and negative predictive value. For the first time, our findings reveal that sHLA-G is a better second trimester screening marker for the detection of T18 fetuses and the combined application of sHLA-G with AFP, free β-hCG, and uE3 could improve clinical screening for T18 fetuses.

The correlation between the quantity of soluble forms of human leukocyte antigen-G in human embryo cultures during cleavage period and pregnancy & implantation rates.

Soluble Human Leukocyte Antigen G Expression in Embryo Culture Supernatants after in Vitro Fertilization and Embryo Transfer

Correlation between the Quantity of Soluble Forms of Human Leukocyte Antigen-G (sHLA-G) in Human Serum during Early Pregnancy Period and the Result of Pregnancy

A meta-analysis of the impact of human leukocyte antigen-G on the outcomes of IVF/ICSI

The Relationship Between sHLA- G Expression of Cleavage Stage Embryo and Embryo Development

Embryonic Soluble Human Leukocyte Antigen-G As a Marker of Embryo Competency in Assisted Reproductive Technology for Chinese Women.

[Expression of Soluble Human Leukocyte Antigen G and Its Relationship to Embryo Development].

The synergy of morphokinetic parameters and sHLA-G in cleavage embryo enhancing implantation rates

[Relationship between trophoblast cell's human leukocyte antigen G expression and early embryo development].

The Role of Human Leukocyte Antigen G in Early Embryo Development and Implantation

Expression of HLA-G Protein in Human Preimplantation Embryos

Differential Expression of Alternatively Spliced Transcripts of HLA-G in Human Preimplantation Embryos and Inner Cell Masses

Expression of HLA-G and its isoforms mRNA in human preimplantation embryos

Altered Amphiregulin Expression Induced by Diverse Lhr Reactivity in Peri-Ovulatory Granulosa Cells is Associated with Ivf Outcomes.

High Expression of L-selectin Ligand in Secretory Endometrium is Associated with Better Endometrial Receptivity and Facilitates Embryo Implantation in Human Being.

Pregnancy Prediction by Beta-Human Chorionic Gonadotropin in Spent Embryo Culture Media in Single Blastocyst Transfer Cycles.

Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester

Correlation Analysis between Spermatozoa Apoptosis in the Ejaculated /Processed and Fertilization Rate/Embryo Quality

Relationship Between Serum Antisperm Antibodies and Anticardiolipin Antibodies and Clinical Pregnancy Outcome in an in Vitro Fertilization and Embryo Transfer Program.

Association Between Follicular Fluid Levels of HMGB1 Protein and Outcomes in Patients Undergoing in Vitro Fertilization/intracytoplasmic Sperm Injection Cycles.

The Correlation Between Concentration of Gonadal Hormone and Clinical Pregnancy Rate in IVF Cycles